Company Close Updates Archives | Email alerts

April 15, 2021, 4:32 p.m. EDT

Moderna Inc. stock underperforms Thursday when compared to competitors

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Moderna Inc. MRNA shed 0.10% to $159.87 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.31% to 14,038.76 and the Dow Jones Industrial Average DJIA rising 0.90% to 34,035.99. The stock's fall snapped a two-day winning streak. Moderna Inc. closed $29.39 below its 52-week high ($189.26), which the company reached on February 8th.

The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. ABBV rose 0.93% to $106.89, Amgen Inc. AMGN rose 2.21% to $255.13, and AstraZeneca PLC ADR AZN rose 1.99% to $50.83. Trading volume (10.3 M) eclipsed its 50-day average volume of 8.8 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Moderna Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.